A systematic review and meta-analysis of familial prostate cancer risk
- PMID: 12780833
- DOI: 10.1046/j.1464-410x.2003.04232.x
A systematic review and meta-analysis of familial prostate cancer risk
Abstract
Objective: To identify published studies quantifying familial prostate cancer risks in relatives of prostate cancer cases and, by meta-analysis, obtain more precise estimates of familial risk according to the family history.
Methods: Thirteen case-control and cohort studies were identified which have reported risks of prostate cancer in relatives of prostate cancer cases. Pooled estimates of risk for various categories of family history were obtained by calculating the weighted average of the log relative risk (RR) estimates from studies.
Results: The pooled RR (95% confidence interval) in first-degree relatives was 2.5 (2.2-2.8). There was evidence that this was highest in relatives of cases diagnosed before age 60 years and that RRs declined with age. The risk for the few men with two affected relatives was increased 3.5-fold (2.6-4.8). RRs to sons of cases appeared to be lower than in brothers; a complete explanation of this observation is uncertain.
Conclusion: Men with a family history of prostate cancer have a significantly greater risk of developing prostate cancer than those with no such history. Risks are greatest for relatives of cases diagnosed when young and those with more than one relative affected.
Similar articles
-
Selenium for preventing cancer.Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4. Cochrane Database Syst Rev. 2018. PMID: 29376219 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Systematic review on urine albumin testing for early detection of diabetic complications.Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300. Health Technol Assess. 2005. PMID: 16095545
-
A systematic review and meta-analysis of familial colorectal cancer risk.Am J Gastroenterol. 2001 Oct;96(10):2992-3003. doi: 10.1111/j.1572-0241.2001.04677.x. Am J Gastroenterol. 2001. PMID: 11693338
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
Cited by
-
Complexities of Prostate Cancer.Int J Mol Sci. 2022 Nov 17;23(22):14257. doi: 10.3390/ijms232214257. Int J Mol Sci. 2022. PMID: 36430730 Free PMC article. Review.
-
[Prostate and breast cancer: similarities and differences].Urologie. 2022 Oct;61(10):1068-1075. doi: 10.1007/s00120-022-01913-5. Epub 2022 Aug 29. Urologie. 2022. PMID: 36038785 Review. German.
-
Association of VDR gene TaqI polymorphism with the susceptibility to prostate cancer in Asian population evaluated by an updated systematic meta-analysis.Onco Targets Ther. 2018 May 31;11:3267-3280. doi: 10.2147/OTT.S151002. eCollection 2018. Onco Targets Ther. 2018. PMID: 29910622 Free PMC article.
-
Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease.Cancers (Basel). 2021 Feb 12;13(4):760. doi: 10.3390/cancers13040760. Cancers (Basel). 2021. PMID: 33673083 Free PMC article. Review.
-
An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis.PLoS One. 2011;6(10):e27130. doi: 10.1371/journal.pone.0027130. Epub 2011 Oct 31. PLoS One. 2011. PMID: 22073129 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical